10-K Decoder · All companies

Sarepta Therapeutics, Inc.

SRPT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$2.20B$1.90B+15.6%
Operating income−$700M$218M
Net income−$713M$235M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$381M$399M−4.5%
Operating income−$9.00M−$103M+91.3%
Net income−$28.5M−$50.6M+43.7%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Sarepta's revenue in FY2025?
$2.20B in FY2025 (Fiscal year ended Dec 31, 2025), +15.6% vs $1.90B a year earlier, per its 10-K filed Mar 2026.
Was Sarepta profitable in FY2025?
No: net income was −$713M and operating income −$700M in FY2025.
What was Sarepta's revenue in Q3 2026?
$381M (−4.5% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.